Jake Taylor-King on the Future of Precision Medicine
Fresh from a long flight back from Seattle (and running on little more than jetlag and coffee), Relation co-founder Jake P. Taylor-King sat down with [...]
Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal Read more
Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decision Read more
AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report Read more
Fresh from a long flight back from Seattle (and running on little more than jetlag and coffee), Relation co-founder Jake P. Taylor-King sat down with [...]
“Biotech isn’t an industry for the faint of heart,” says Peter Crane, CEO and co-founder of Entelo Bio. It’s a sentiment that runs through his [...]
“There’s No Free Lunch in Drug Development” - Quin Wills on Tackling the Liver Knowledge Gap “Science is hard, but getting the people formula right [...]
“You Have to Be Completely Crazy” – Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health From the ER to entrepreneurship, [...]